Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 13, 2019

SELL
$1.59 - $3.47 $22,654 - $49,440
-14,248 Closed
0 $0
Q2 2019

Aug 16, 2019

SELL
$1.93 - $4.59 $91,925 - $218,621
-47,630 Reduced 76.97%
14,248 $28,000
Q1 2019

May 13, 2019

SELL
$2.77 - $4.38 $124,760 - $197,275
-45,040 Reduced 42.13%
61,878 $267,000
Q4 2018

Feb 13, 2019

SELL
$3.03 - $5.0 $15,452 - $25,500
-5,100 Reduced 4.55%
106,918 $340,000
Q2 2018

Sep 27, 2018

SELL
$4.2 - $5.95 $657,967 - $932,121
-156,659 Reduced 58.31%
112,018 $599,000
Q2 2018

Aug 10, 2018

BUY
$4.2 - $5.95 $657,967 - $932,121
156,659 Added 139.85%
268,677 $9.65 Million
Q1 2018

May 14, 2018

BUY
$3.3 - $5.15 $22,572 - $35,226
6,840 Added 6.5%
112,018 $560,000
Q3 2017

Nov 14, 2017

BUY
$2.7 - $3.75 $283,980 - $394,417
105,178
105,178 $394,000

Others Institutions Holding HBIO

About HARVARD BIOSCIENCE INC


  • Ticker HBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 41,636,500
  • Market Cap $89.1M
  • Description
  • Harvard Bioscience, Inc. develops, manufactures, and sells technologies, products, and services that enables fundamental research, discovery, and pre-clinical testing for drug development in the United States and internationally. The company offers cellular and molecular technology instruments, such as syringe and peristaltic pump products, as w...
More about HBIO
Track This Portfolio

Track United Services Automobile Association Portfolio

Follow United Services Automobile Association and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

News

Stay updated on United Services Automobile Association with notifications on news.